Tohen Mauricio, Khalsa Hari-Mandir K, Salvatore Paola, Zarate Carlos A, Strakowski Stephen M, Sanchez-Toledo Jesús Pérez, Baldessarini Ross J
Department of Psychiatry, University of New Mexico Health Sciences Center, 2400 Tucker Ave, Albuquerque, NM 87131.
Department of Psychiatry, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
J Clin Psychiatry. 2016 Jun;77(6):781-8. doi: 10.4088/JCP.14m09414.
Early course in contemporary, clinically treated, nonaffective psychotic disorders other than schizophrenia remains incompletely defined.
We prospectively, repeatedly, and systematically assessed 114 patients hospitalized for a first episode of DSM-IV-TR nonaffective psychotic illness for ≥ 2 years (1989-1996) using structured (Structured Clinical Interview for DSM-III-R, Patient Edition; Clinical Global Impressions scale; Scale for the Assessment of Negative Symptoms; Scale for the Assessment of Positive Symptoms; and the expanded version of the Brief Psychiatric Rating Scale) and unstructured (best-estimate procedure, life charting) naturalistic follow-up procedures and survival analysis.
Duration of untreated psychosis (22 ± 38 months) was longest with schizophrenia. Within 2 years, syndromal remission sustained for ≥ 8 weeks (recovery) was attained by 75 subjects (65.8%); median latency to syndromal recovery was 9.4 (95% CI, 5.7-13.3) weeks and was shorter with cycloid features, initial diagnosis of brief psychosis or schizophreniform disorder, and shorter initial hospitalization. Functional recovery within 2 years was achieved by 28 of 68 subjects (41.2%), more often without initial mood-psychomotor instability or homicidal ideation. New episodes occurred in 52 of 114 subjects (45.6%) and were more likely with less affective flattening, younger age, and white race. Median time to new episodes (43.7 [27.9-70.6] weeks) was earlier with initial first-rank auditory hallucinations, substance abuse, and functional nonrecovery. Diagnosis changed to other nonaffective, schizoaffective, or affective disorders within 2 years in 62 of 108 cases (57.4%).
Three-quarters of patients presenting in first lifetime, nonaffective psychotic episodes achieved recovery within 2 years, but only 41% returned to baseline functioning, and nearly half experienced new episodes. Patients with schizophrenia had the longest duration of untreated psychosis. A majority changed diagnosis, indicating instability of some DSM psychotic-disorder diagnoses.
除精神分裂症外,当代临床治疗的非情感性精神障碍的早期病程仍未完全明确。
我们对114例因DSM-IV-TR非情感性精神病首次发作而住院≥2年(1989 - 1996年)的患者进行了前瞻性、重复性和系统性评估,采用结构化(DSM-III-R患者版结构化临床访谈、临床总体印象量表、阴性症状评估量表、阳性症状评估量表以及简明精神病评定量表扩展版)和非结构化(最佳估计程序、生活图表记录)的自然主义随访程序及生存分析。
精神分裂症患者的未治疗精神病持续时间(22±38个月)最长。两年内,75名患者(65.8%)实现了持续≥8周的综合征缓解(康复);综合征康复的中位潜伏期为9.4(95%可信区间,5.7 - 13.3)周,具有循环型特征、初始诊断为短暂精神病性障碍或精神分裂症样障碍以及初始住院时间较短的患者潜伏期更短。68名患者中有28名(41.2%)在两年内实现了功能康复,无初始情绪-精神运动不稳定或杀人观念的患者更常实现功能康复。114名患者中有52名(45.6%)出现了新发作,情感平淡程度较低、年龄较小和白人种族的患者更易出现新发作。初始有一级幻听、物质滥用和功能未恢复的患者出现新发作的中位时间(43.7[27.9 - 70.6]周)更早。108例患者中有62例(57.4%)在两年内诊断变为其他非情感性、分裂情感性或情感性障碍。
四分之三首次出现非情感性精神病发作的患者在两年内实现了康复,但只有41%恢复到基线功能,近一半患者经历了新发作。精神分裂症患者的未治疗精神病持续时间最长。大多数患者诊断发生了变化,表明一些DSM精神病性障碍诊断不稳定。